There is so much that scientists have yet to learn about the universe, and understanding the matter that makes up the universe is a large task for scientists to undertake. Researchers at Stony Brook University will soon have new opportunities to increase their research thanks to a newly established research center.Read More
Science Market Update
The National Institute of Mental Health recently awarded a $2.3M Biobehavioral Research Award for Innovative New Scientists (BRAINS) grant to Dr. Matthew D. Lerner, an assistant professor in the Department of Psychology at Stony Brook University. The grant will provide funding for Dr. Lerner's project, “Optimizing Prediction of Social Deficits in Autism Spectrum Disorders,” a study which aims to help youth with autism overcome social challenges.
(Image courtesy of Wikimedia Commons)
Anti-fungal research at New York's Stony Brook University earned $6 million in grants from the National Institute of Health. Dr. Maurizio del Poeta’s breakthrough in attacking deadly fungus came from a recent research project that yielded an unexpected result that might lead to a vaccine. He and his team were searching for a gene that would metabolize a fungal sphingolipid. Instead, the gene he mutated caused mice that were exposed to it to become resistant to fungal infections. In an article on the Stony Brook University’s news site, Dr. Poeta said , “We think that this discovery will open the road to a new vaccination strategy against fungi.”Read More
Tags: Northeast, New York, Stony Brook University, East Coast, NY, NIH grant, new research grant, SunySB, Fungal Infections, BioResearch Product Faire™, BioResearch Product Faire, NIH awards 2017, 2017 research funding
For over 50 years, Stony Brook University in New York has been a venue for thousands of groundbreaking discoveries made by prominent medical researchers and clinicians.Read More
The start of the 2016 academic year will see growth in the research facilities at Stony Brook University campus in New York, as a new research building is completing construction and scheduled to open.Read More
Insulin is a vital hormone that plays a major role in the metabolism: without insulin, humans would not be able to break down carbohydrates or digest food for energy. Insulin lowers blood glucose levels, stores excess glucose as glycogen and reduces glucose production in the liver. Many people, however, have trouble using insulin effectively. Forms of insulin resistance can lead to pre-diabetes or type 2 diabetes, as well as other serious health problems.
Stony Brook University recently named an endowed professor for cancer research at an Investiture Ceremony this spring. Dr. Yusuf A. Hannun will have a sizeable amount of science research funding available for conducting cancer research as the Joel Strum Kenny Professor in Cancer Research. Dr. Hannun is a research lab scientist well-known around the globe for his cancer research and already serves as Director of the Stony Brook University Cancer Center.
Stony Brook University recently received $60 million in new funding to build a state-of-the-art Innovation and Discovery Center on its Research and Development Park campus. The center will include 200,000 square feet of new lab space at Stony Brook University as well as office space for startup businesses. The new funding comes from Governor Andrew M. Cuomo’s START-UP NY initiative, which aims to give businesses tax breaks to start up, relocate, or add new locations in New York by working with New York public and private universities.
Researchers at Stony Brook University recently received $1.2 million in life science funding from the NIH for a Sphingolipids in Cancer Biology and Therapy project led by Yusuf Awni Hannun. According to Stony Brook University, Dr. Hanuun is a renowned molecular biologist and physician-researcher interested in the molecular mechanisms of cancer. In 2012, he was appointed director of the Stony Brook Cancer Center, and he also serves as the Joel Kenny Professor of Medicine and Vice Dean for Cancer Medicine. The NIH RePORTER gives some background information on the project receiving NIH life science research funding:
Researchers at Stony Brook University in collaboration with colleagues at Johns Hopkins School of Medicine used DNA sequencing methods to make a new discovery: the direct causation of exposure to aristolochic acid (AA), which is found in a plant that’s been used in herbal remedies for thousands of years, in the development of urothelial cancer.